Lars Bossen

Nonselective β‐blockers do not affect mortality in cirrhosis patients with ascites: Post Hoc analysis of three randomized controlled trials with 1198 patients

Lars Bossen, Aleksander Krag, Hendrik Vilstrup et al. · Hepatology · 2015 · 122 citations

Pharmacy, Biostatistics, Pharmacotherapy +17

Men with biopsy‐confirmed hepatocellular adenoma have a high risk of progression to hepatocellular carcinoma: A nationwide population‐based study

Lars Bossen, Henning Grønbæk, Peter Lykke Eriksen et al. · Liver International · 2017 · 31 citations

Medicine, Oncology, Pathology +17

Serum sodium as a risk factor for hepatic encephalopathy in patients with cirrhosis and ascites

Lars Bossen, Pere Ginès, Hendrik Vilstrup et al. · Journal of Gastroenterology and Hepatology · 2018 · 31 citations

Medicine, Pharmacology, Hepatic Pharmacotherapy +16

Effect of proton pump inhibitors on the risk and prognosis of infections in patients with cirrhosis and ascites

Gitte Dam, Hendrik Vilstrup, Per Kragh Andersen et al. · Liver International · 2018 · 29 citations

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +15

Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitis

Lars Bossen, Paola Rebora, Francesca Bernuzzi et al. · Liver International · 2020 · 28 citations · Full text

Medicine, Immunology, Internal Medicine +17